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Introduction 
Driving under the influence of  drugs (DUID) has focused the 
attention in many countries and prevention measures, administra-
tive, judicial procedures and policies have been studied to deal 
with the problem, trying to find effective solutions. Many papers 
are being published referring to the presence of  drugs of  abuse 
in drivers and analytical results of  samples of  the population are 
being provided.
Matrices as blood, urine and oral fluid (OF) have been tested with 
different and acceptable results. Reviews about the use of  OF 
in drug analysis and in therapeutic and toxicological monitoring 
are numerous as the one reported by Shikha et al., [1] where the 
sample integrity problems and the advantages and limitations of  
OF in drug screening programmes are examined, as well as the 
relation to the pharmacokinetics of  drug metabolism and excre-
tion in this matrix. Parent drugs are often found in OF where only 
their metabolites may be found in urine. OF offers the possibility 
of  comparison of  unbound pharmacology active drug concentra-
tions to pharmacodynamic effects, but with a shorter detection 
window than urine [2].
However, the lack of  concordance studies examining both urine 
and OF drug levels and kinetics in the clinical setting is of  some 
concern [3]. The utility of  OF as a sample matrix for the detec-
tion of  drugs abuse is known time ago, since it can be used in 
various settings and situations, such as roadside drug testing and 
clinical and forensic case studies. OF is widely recognised as a 
tamper-resistant screening method, which can identify drug use 
as accurately as blood testing, given the high correlation between 
the two fluids. Hold et al., [4] have reviewed OF as a biological 
sample to contribute to the interpretation of  drugs concentration.
 
Advances in analytical techniques, particularly chromatography 
linked to tandem mass spectrometry, are helping to promote OF 
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analysis. This matrix is used testing by immunoassay biochemical 
test where the presence or concentration of  a substance is detect-
ed. Nevertheless, it is a screening test and confirmatory analyti-
cal technique may be used after the screening test when positive 
results are obtained as Gas Chromatography/Mass Spectrometry 
(GC/MS) or Liquid Chromatography/mass Spectrometry (LC/
MS). Confirmatory analysis, GC/MS or LC/MS, must be carried 
out to meet the desired sensibility because low amounts of  sam-
ple are usually available for analysis [5]. 
OF has some disadvantages. For example, the volume of  speci-
men collected may be too low for testing and for subsequent labo-
ratory confirmation testing.  
The aims of  this review is to report studies published about this 
issue in the last years carried out using OF as matrix to detect driv-
ers under the influence of  drugs of  abuse Data base MEDLINE 
has been consulted from 2000 until now. Results were focused on 
cocaine (COC), opiates (OPI), cannabis (THC), amphetamines 
(AM) and methamphetamines (MAM) analytes. Reference to test-
ing devices, pharmacokinetic, correlation OF/blood results and 
drugs and impaired driving are also provided in this review.
Background
Several surveys have been performed since the 1980s using OF 
as matrix for detection of  drugs of  abuse and medicaments. In 
1990’s when devices suitable for the use of  this matrix were devel-
oped and marketed, researchers encountered problems related to 
insufficient sample volume and insufficient sensitivity of  the ana-
lytical methods. Along the time progress has been shown in sam-
ple collection, knowledge of  toxicokinetics in OF, performance 
of  on-site and laboratory-based immunoassays and confirmation 
methods.
At the end of  the 90s, in this context, the European Union 
launched to develop road site drug testing devices for drugs 
of  abuse. The Roadside Testing Assessment (ROSITA) project 
(ROSITA 1 and ROSITA-2) continued evaluating the usability 
and analytical reliability of  the onsite OF drug testing devices 
as the integrated project DRUID (Driving Under the Influence 
of  Drugs and Medicaments) trying to find information concern-
ing the use of  drugs or medicines affecting ability to drive safely. 
Analytical techniques for detection of  drugs in OF were reviewed 
with emphasis on applications used in European Union roadside 
testing projects. Project DRUID was a part of  the 6th Framework 
Programme 1 to fight against substance dangerous for road safety. 
ESTHER (Evaluation of  oral fluid Screening devices by TISPOL 
to Harmonize European police requirements) were programs and 
organizations included in DRUID Project as well as DVLA (Driv-
ing vehicle licensing agency) in Great Britain. All these projects 
were evaluating the performance of  different devices.
 
With time, the new technologies have enabled the development of  
the kits evaluated in these projects with enhanced performance.
Cut-Offs
In OF on-site drug screening, detection limits are set by the labo-
ratory or the device manufacturer and there are significant differ-
ences among them. It is important to set the adequate cut-offs for 
their detection and confirmation. As a rule, the detection limit val-
ues used were those set by the National Institute on Drug Abuse 
(NIDA), In the ROSITA project, the Substance Abuse and Men-
tal Health Services Administration (SAMHSA) guidelines recom-
mended a confirmation cut-off  level in OF [6]. 
Several studies have reported results establishing different cut-
offs. Engblom et al., [7] investigated AM concentrations in both 
OF and whole blood samples of  persons suspected of  DUID. 
The cut-off  for OF samples was 25µg/L and for whole blood 
sample 20µg/L. The results nevertheless indicated that the cut-
off  used for AM in OF (25µg/L) could be higher to correspond 
to the window of  detection given by the level of  20µg/L in whole 
blood. 
When using equivalent cut-off  concentrations other studies indi-
cate that the prevalence of  drugs in samples of  OF is the same 
as the prevalence in blood. The cut-offs in OF may be higher or 
lower than that in blood in accordance with the median OF to 
blood concentration ratio (OF/B), but it is also influenced by the 
skewness of  the distribution of  OF/B ratios. Regression formu-
lae for the concentrations corresponding to selected percentiles in 
OF versus the same concentration percentiles in blood were de-
termined. The accuracy when multiplying the cut-off  thresholds 
in blood with the average and median OF/B ratios to estimate 
equivalent cut-offs in OF fluid was also investigated. These results 
were obtained from a population of  4080 subjects. Prevalence 
regression gave the most accurate results [8].
Pharmacokinetics
Although there are a number of  factors that affect drug concen-
tration in OF, there appear to be a reasonable correlation between 
blood and OF concentrations of  drugs but local absorption of  
drug, in situations where drug may be present in the oral cavity 
(smoking or sublingual absorption) may influence in the results 
Drug may be also deposited by intranasal administration which 
must be considered. Moreover, contamination of  the sample by 
food, beverages, or other adulteration agents may pose additional 
problems to the analytical method [9]. Drugs generally appear in 
OF by passive diffusion from blood. Drug metabolites can be also 
detected in OF. Several studies agree that there may be a close 
correspondence between drug and metabolite concentrations in 
OF and in blood, but interpretation of  OF results for drugs of  
abuse should evaluate the test results in the context of  program 
requirements [10].
Several studies deals with  the transference mechanisms of  drug 
transfer from blood into OF and the influencing factors, as the 
methods of  sample collection, preparation, analysis of  the abused 
drugs in OF and the relationship between abused drugs content 
in OF and in blood. It should be interesting to estimate abused 
drugs concentrations in blood by via their saliva concentrations 
[11]. Another fact that can influence the OF with plasma drug 
concentration correlation is that depending upon the lipophility 
and pKa of  the drugs and its metabolites concentration in OF can 
be much higher or lower than in plasma [12].
Drugs concentrations are generally lower in OF than in urine [13]. 
In general, drug testing of  OF detects drug use during the previ-
ous 24–48 hours [14], regardless of  the route of  administration 
although the selection of  cut-offs plays an important role in the 
length of  the detection window. OF/B ratios vary from drug to 
drug, from person to person, and even intraindividually making 
therapeutic drug monitoring in OF challenging [15].
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Correlation
Recently this relationship was evaluated by studying the linear cor-
relation of  concentrations and calculating the OF/B ratios for 
different substances The median OF/B ratios were, for AM 19-
22, for OPI 1.8-11, for COC and metabolites 1.7-17, for THC 
14; results also confirmed that there was a lot of  inter-individual 
variation in the OF/B ratios. For all substances, except THC a 
correlation between the OF and whole blood concentrations was 
observed but due to large variation seen here, drug findings in OF 
should not be used to estimate the corresponding concentrations 
in whole blood (or vice versa) as it would be desirable [16].
Wille et al., [17] also studied the relationship between the OF/B 
ratios and scatter plots and trend lines of  the blood and OF con-
centrations were calculated for AM, COC, OPI and THC. A wide 
range was also found, >1 for AM (0.5-182), COC 22 (4-119), OPI 
2 (0.8-6) for THC an OF/B ratio of  15 (0.01-569) was found al-
though the time of  last administration and the dose and the route 
of  administration was unknown. It is important to stand out that 
these results agree with previous results reported and also con-
firm that the wide range of  the ratios did not allow calculations 
of  the blood concentration of  drugs from OF data. 
Regarding to the presence of  one or more drug in OF and cor-
relation with blood was studied by Toennes et al., and variability 
of  OF analysis results in relation to blood/serum. In a sample 
of  177 cases in 45% of  the cases single-drug use was found, and 
in 50% poly-drug use was found. Cannabis was most prevalent 
(78%) and 70% of  these individuals were also positive for THC 
in serum. Overall, 97% of  OF samples positive for any substance 
were also positive in serum [18]. Garcia- Repeto et Soria [19] has 
also reported the correlation of  psychoactive substances between 
OF and blood. 
Bogstrand et al., [20] investigated the association between drug 
type and arrest for driving under the influence of  drugs by cal-
culating odds ratios (ORs) using a case-control design in drivers; 
794 subjects involved in road traffic crashes and 1944 arrested 
for other reasons, The controls were random drivers in normal 
traffic. Blood samples from cases and OF samples from controls 
were analyzed for 15 drugs. The most prevalent illicit drug in 
the control group was THC (0.58%), which was also commonly 
found in samples from drivers arrested due to road crash or other 
reasons (15.6%, 21.8% respectively) AM/MA was most prevalent 
among arrested drivers involved in crashes (30.6%) and drivers 
arrested for other reasons (56.9%), whereas only 0.18% of  the 
control group was positive for AM/MAM. The single-use sub-
stances which gave highest OR for police arrest were AM/MA. 
Combinations of  two or more drugs yielded higher ORs than the 
use of  single substances.
Times of  Elimination
In the area of  pharmacokinetic another variable of  interest is the 
course and time of  elimination of  drugs and. Controlled studies 
that have measured drug concentrations in OF following dosing 
regimens have been identified over the last years. These studies 
show that the AM including designer AM, COC, THC usually 
have similar time-courses to that in plasma. Following common 
doses peak OF concentrations exceed 0.1µg/mL and often even 
1µg/mL. The drug concentration will depend on whether a dilu-
tion occurs with when a buffer solution is used as part of  the 
sampling procedure. Results can be affected and it must be con-
sidered [21].
Additional evidence for interpreting COC and metabolite con-
centrations in OF was provided in another controlled study [22] 
carried out on a closed research unit for up to 10 weeks under 
constant medical supervision, to determine time of  elimina-
tion and half  life of  COC; 19 participants were administered 75 
mg/70 kg subcutaneous COC and 14 received 150 mg/70 kg. The 
disposition of  COC, and its metabolite benzoylecgonine (BE) 
and ecgonine methyl ester (EME) into OF was determined after 
administration. In OF, COC first appeared, 0.08 to 0.32 hours 
after dosing and was rapidly eliminated with half-lives of  1.1 to 
3.8 hours. BE and EME were first detected 0.08 to 1.0 hours after 
dosing with longer half-lives of  3.4 to 13.8 (BE) and 2.4 to 15.5 
hours (EME). OF and plasma concentrations were significantly 
correlated for COC, BE, and EME There were no significant dif-
ferences in first and last detection times with the 8-μg/L cut-off  
proposed by the SAMHSA or the 10-μg/L cut-off  from DRUID. 
Due to its high prevalence cannabis is one of  the illegal drugs 
most studied and THC pharmacokinetics has been reported in 
occasional and chronic users. Toennes et al., [23] have studied the 
elimination half-life (1.6+/- 0.4 h); the OF/serum ratios were 0.3 
to 425 without differences between the two groups. The large 
variability observed precludes a reliable estimation of  THC serum 
concentrations from OF. 
Van der Linden et al., [24] carried out other controlled study to 
determine time of  elimination of  THC in OF during roadside 
surveys. 2957 subjects were asked to report their use of  drugs 
during the previous two weeks and to indicate the time of  their 
last intake. THC was analyzed and frequencies in the time cat-
egories were calculated and compared with toxicological results. 
Diagnostic values were calculated for the time categories in which 
positive findings were to be expected (<4h and <24h, respectively 
for THC and its metabolite THCCOOH in blood, <12h for THC 
in OF. Most of  subjects self-reported cannabis use was more 
than 12h before driving. The sensitivity of  the questionnaire was 
low, while the specificity and accuracy were high. As conclusion 
self-report largely underestimates driving under the influence of  
cannabis, particularly recent cannabis use; therefore analysis of  
biological samples is necessary.
Devices
Reliable rapid on-site oral fluid tests are needed to be used in po-
lice controls to detect impaired and drugged drivers Description 
of  numerous devices is not the objective of  the review although 
we report some of  them. Along the time testing technology is 
improving for accurate and sensitive detection of  drug use. How-
ever, manufacturers do no publish OF or analyte’s recoveries thus 
placing the burden to document these factors on individual inves-
tigators. Rosita-1 y Rosita-2 projects focused to evaluate the ef-
fectiveness of  point of  collection OF drug detection. The devices 
were evaluated for their ability to meet manufacturers’ claims and 
proposed cut-offs concentration for illegal drugs. Drugwipe, Se-
curetec, Ottobrunn, results were compared after confirmatory 
mass spectrometry analysis [25].
Peherson et al., [26] evaluated the performance of  two on-site 
oral fluid drug-testing devices. The evaluation was performed for: 
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AM, THC, COC, and OPI. Both tests seemed to perform quite 
well for AM and THC although an evaluation of  COC and OPI 
tests was not applicable because of  the very low number of  posi-
tive cases.
The performance of  eight devices was assessed using cut-offs at 
a low levels In Belgium, Finland and the Netherlands as a part 
of  the EU-project DRUID The sensitivity of  OPI results ranged 
between 69 and 90% and acceptable results were found for AM. 
The THC and COC tests of  the devices showed a still lack of  
sensitivity [27]. 
Within the same project and based in the toxicological cut-off  
as set in DRUID project the performance of  the Rapid STAT 
DrugWipe 5/5+ and Dräger Drug Test 5000 on-site oral fluid de-
vices was evaluated with random OF specimens from car drivers 
in North Rhine-Westphalia and results of  OF and urine on-site 
tests were compared to serum. The sensitivities obtained showed 
wide range (50%-95%) THC specificity was especially low, 29% 
and 47% due to low cut-off  concentrations. These data were simi-
lar to those obtained from the literature. In DRUID project was 
evident that OF devices still show a lack of  sensitivity for MA 
and specificity for THC. The sensitivity for THC came out higher 
than compared to the literature, but specificity was not yet satis-
factory (<90%) [28].
DrugWipe5/5+, was evaluated by Finish police. The device per-
formed quite well in detecting AM, but the performance of  the 
THC, OPI and COC tests was not at the same level [29]. 
Goessaert et al., [30] evaluated the Varian Oralab 6 and collected 
OF samples from 250 subjects, one with the Varian Oralab6 and 
one with the StatSure Saliva Sampler. Two cut-off  values were 
used in the evaluation (Varian and DRUID cut-off  values).The 
conclusion was that specificity of  the Oralab 6 is generally good. 
For both cut-offs, sensitivity was low for COC and THC. As con-
clusion, the Varian Oralab 6 test was not sensitive enough to be 
applied during roadside police controls.
Advanced studies have evaluated the efficacy of  using IgG con-
centration, or any other endogenous marker, as a measure of  OF 
specimen validity. Preliminary rinsing experiments with different 
volumes of  water did not reduce the OF IgG concentration be-
low proposed specimen validity criteria [31].
Recently Roche DAT has marketed another homogeneous screen-
ing assay for illegal drugs. Sensibility and specificity were > 94% 
and agreement was >96% which means a good performance [32]. 
Research to evaluate applicability of  four commercial on-site OF 
devices was carried out by Stran-Rossi et al to determine sensitivi-
ties of  COC, THC and AM with different results [33].
Wille et al., [34] evaluated three devices that demonstrated re-
spectively a good sensitivity. For COC screening, sensitivities 
were lower. One of  the devices, the DrugTest 5000 test cassette, 
a newer version, demonstrated a sensitivity of  93%, indicating an 
increased detection of  THC using new generation OF screening 
tests with lowered cut-offs. 
Cozart DSS 801 device was tested to establish statistical param-
eters of  the tests for THC and COC [35]. The sensitivity, specific-
ity, predictive positive value, predictive negative value, likelihood 
positive ratio and likelihood negative ratio for COC and THC 
were calculated. Accuracy was 91% for COC and 86% for THC. 
OF samples were compared with collected OF and urine samples 
and performance of  two devices established to detect drug use in 
an investigation of  drug impaired driving in a sample of  92 sub-
jects. Overall, 41% of  these drivers were confirmed positive for 
the presence of  one or more drugs. The most frequently detected 
drugs were THC (30%), and COC (10%). The most notable dif-
ference in performance was the DDT5000's better sensitivity in 
detecting marijuana use compared to Affiniton Drugwipe device 
[36].
In DUID context, a pilot study was developed in the Gauteng 
and Western Cape provinces (South Africa) to test four sub-
stance use screening devices developed in Germany in a sample 
of  motorists, to assess the utility for detecting driving under the 
influence of  drugs as part of  the standard road block operations 
of  local law enforcement agencies; 14% of  the 269 drivers drug-
screened tested positive for drugs. AM, MA and COC were the 
most common drugs of  impairment detected. The results suggest 
that under normal enforcement procedures only 76% of  drivers 
impaired by alcohol and other drugs would have been detected. 
One advantage was that in more than 70% of  cases the tests were 
administered within 5min and this is likely to improve with more 
regular use [37].
A recent evaluation of  a second-generation handheld OF testing 
device, the Alere DDS2 Mobile Test System (DDS2), was probed. 
Drivers randomly stopped at various locations across California, 
in 2012, were asked to submit voluntarily to a questionnaire re-
garding their drug use. OF samples were collected and 50 drivers 
were asked to submit an additional OF sample using the DDS2 
collection device; samples were analyzed by using the DDS2 mo-
bile test system. In 24%, the device failed to provide a valid result. 
Thirty-two of  the 38 collected samples were negative for all drugs; 
five were positive for THC and one was positive for MA using 
the mobile device. These results corresponded exactly with the 
laboratory-based results from the Quantisal OF collection [38]. 
More specific results of  these devices and their performance are 
not supplied in this review and may be consulted in correspond-
ing published articles.
OF Reports Published In Specialized Literature
In a number of  Australian States police services conducted a re-
search to provide the prevalence of  drugs driving in a sample 
of  motorists in Queensland. 3.5% of  the sample was confirmed 
positive for al least one illegal substance. THC was the most com-
mon drug detected in OF followed by AM [39]. 
In the same country at least one illicit drug was detected in 96% 
of  drivers in 853 OF samples submitted by Victoria Police. In this 
sample the most common drug was the MA (77%) followed by 
THC (42%). COC was detected in 8% of  the cases [40]. 
In Norway, drug use, was examined analysing OF samples. Al-
cohol or drugs were found in 1.9% and 6.6% of  the samples of  
the truck drivers and car drivers [41]. Prevalence of  driving with 
blood drug concentration above legal limits in blood based on 
drug concentration in OF was estimated. 3.8% were positive for 
drugs in OF [42]. 
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In south eastern Norway comparison of  drug use in drivers by an-
alyzing OF, by urban and rural areas, was carried out in a roadside 
survey in 2005-2006. Samples of  OF were analyzed for alcohol or 
drugs, for a total 28 psychoactive substances. Illegal drugs were 
significantly more frequently detected in samples from drivers in 
urban areas than in rural areas, The time of  the sampling was a 
variable of  importance since the illegal drugs were most com-
monly found in samples collected during late night on weekdays 
or weekends (2.8%-3.2%). The most prevalent substance was 
cannabis THC (1.1%), The prevalence of  driving with drug con-
centrations above the Norwegian legislative limits for blood was 
estimated to be 0.6 % for illegal drugs [43].
In Denmark, OF samples were collected randomly from 3002 
drivers using a sampling scheme stratified by time, season, and 
road type while 0.3% of  the drivers tested positive for one or 
more illicit drug at concentrations exceeding the Danish legal 
limit. THC, COC, and AM were the most frequent illicit drugs 
detected [44].
Another random sample of  night drivers in British Columbia 
indicates that cannabis and COC were also the drugs most fre-
quently detected; 10.4% of  78 samples tested positive for illegal 
drugs [45]. More data are provided for British Columbia in road 
survey issues. Beirness et Beasley [46] reported a 31.8% of  COC, 
11.9% OPI, 4.8% AM and 4.4% MAM in Columbia roadside 
study of  drivers and accounted in 8.3% of  all positive drug cases. 
In Belgium 18% of  results COC positives were found in a sample 
of  drivers [47].
In South-East Hungary in the framework of  the DRUID EU-6 
project, to determine the and the most frequent illicit drug con-
sumption (AM, THC, OPI, COC) a roadside survey was conduct-
ed in the population, 3110 drivers; illicit drugs were detected in 
27 cases (0.99%). Illicit drug consumption was the highest among 
young men, during the spring, and on the week-end nights. Au-
thors conclude that In comparison to international European av-
erages, the alcohol and illicit drug consumption was low [48]. 
According to data reported for Finland among drivers suspected 
of  driving under the influence of  drugs, there is a high percent-
age of  licit and/or illicit drug use. The drugs of  most concern 
are AM and AM-type substances, COC, THC, OPI, among other 
psychoactive drugs [49]. 
In The Netherlands and Belgium randomly selected car drivers 
and drivers of  small vans were included between 2007 and 2009. 
Blood and OF samples were analyzed for 23 substances, whereas 
the single illicit drugs were more common in Dutch traffic (2.2%) 
than in Belgian traffic (0.6%) [50].
Spain has achieved random, roadside controls of  3302 repre-
sentative sample of  Spanish drivers, including OF analysis for 
24 psychoactive substances; 11% were found positive to any il-
licit drug. The most common illicit drugs among Spanish drivers 
were THC (7.7%) or COC (3.5%) either alone or combined with 
other substances. Alcohol and COC positive cases were more fre-
quently found among drivers of  urban roads. Alcohol and drugs 
cases were also more likely found those driving on urban road 
(OR=2.17) and driving at night time [51].
In our laboratory, in Spain, we carried out a study focused on the 
study of  prevalence of  drugs of  abuse in a sample population 
of  drivers of  motor vehicles. 3468 OF samples came from local 
police activities, during the years 2007 until June 2010 in Barce-
lona. After confirmation results showed a cannabis prevalence in 
2064 samples (59.5%), COC in 1952 samples (56.2%) opiates in 
258 (7.4%) and AMP in 69 samples. Results show that THC was 
the most prevalent in the study, followed by COC. Data are valu-
able in order to initiate sanction proceedings in Spanish legisla-
tion and also as signs of  recreational drugs consumption, which 
provide information [52]. The prevalence of  COC in our study 
is higher than in other reports ranging between 0.1-8,4%) but in 
other studies a higher prevalence was found between 10, 2% and 
32, 7% [53-58].
Penning et al, in Netherland, report data studies indicating that 
1-15% of  drivers are under the influence of  drugs when driving. 
Road side studies show the most test positive for the use of  alco-
hol and or THC [59]. 
In Belgium in paired samples of  blood and OF, 2.949 randomly 
selected drivers participated in a roadside survey Samples were an-
alyzed for 11 illicit substances or metabolites; 28 (1.0%) had drug 
concentrations above the legal cut-off  in blood and 71 (2.6%) 
were above the legal cut-off  in OF [60]. 
Vindenes et al reported the study of  the Norwegian police in a 
population suspected of  driving under the influence of  drugs. 
If  drugs detected in blood were found in OF and if  interpreta-
tion of  OPI findings in OF was as conclusive as in urine was 
investigated. The three matrixes were collected from 100 drivers 
suspected of  drugged driving. The analysis showed a good cor-
relation between the findings in urine and OF for AM, COC/BE, 
OPI, COC, opiate metabolite, and 6-monoacetylmorphine (6-
MAM) were more frequently detected in OF than in urine. Drug 
concentrations above the cut-off  values were found in samples of  
OF and urine in the cases positive for OPI. The use of  cannabis 
was confirmed by detecting THC in OF and its metabolite THC-
COOH in urine. In 34 of  46 cases the use of  THC was confirmed 
both in OF and urine. All the drug groups detected in blood were 
also found in OF [61]. 
Brazil and Norway, two different countries regarding legislation 
history, enforcement and penalties for DRUID, were compared. 
The proofs were conducted on week-ends between noon and 
midnight. Samples of  OF were collected for analysis of  drugs. 
High participation rates of  94-97% were obtained in both coun-
tries. AM or COC were found in samples from 1.0% of  drivers 
in Brazil and 0.3% in Norway. The prevalence of  AM was highest 
among Brazilian truck drivers (3.6%); THC was found in samples 
from 0.5% of  drivers in Brazil and 1.0% in Norway. Differences 
for drugs may be related to different patterns in the use of  stimu-
lants, cannabis and medicines [62]. 
Among Brazilian drivers, the prevalence of  psychoactive drug was 
investigated as a part of  a larger designed project. About 10% of  
the 2235 OF samples collected from drivers on Brazilian Federal 
highways were positive) for at least one analyte investigated. Alone 
or in combination with other drugs, COC/metabolites were the 
analytes most detected in the samples (5.8%), followed by am-
phetamines/metabolite (3.1%), THC (1.1%) and OPI (0.4%). De-
tection of  at least two psychoactive drugs from different classes 
accounted for 9.3% of  the 236 positive samples. COC was found 
at higher levels in the samples (up to 1165ng/m) [63]. 
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In the same country, Brazil, the use of  stimulant drugs to avoid fa-
tigue and to maintain the work schedule was also reported. Among 
1250 professional drivers OF samples were collected from truck 
drivers on the roads during morning hours to investigate the inci-
dence of  alcohol and illicit drug use among truck drivers on São 
Paulo state roads between the years 2002 and 2008. The samples 
were tested for the presence of, COC, THC and AM/MA. Of  the 
total analyzed samples, 3.1 % were positive 0.64 % for AM, 0.56 
% for COC, and 0.40 % for THC. In one case, both COC and 
THC were detected [64]. 
In San Francisco 175 drivers and 272 passengers were surveyed 
among young adults. The survey was achieved in music dance 
events in young adults aged 18-34 who are at high-risk for crashes 
to locations where alcohol sales are the principal source of  rev-
enue. OF samples were analyzed and up to 30% of  these attend-
ees may also use drugs. However, there were no differences in 
the prevalence of  drug use among drivers and passengers. These 
findings suggest that the effort by young adult drivers to avoid 
alcohol-impaired driving appears to be reducing the number of  
drivers with high blood alcohol levels returning from drinking lo-
cations, by about one third. However, there is no similar pattern 
for drugged driving [65].  
In the United States association between alcohol and drug use 
is not uncommon among drivers. Until the 2007 the prevalence 
of  drugs among drinking drivers on U.S. roads was unknown by 
the national Roadside Survey and surveys were conducted on 
weekend nights from July-November 2007. Of  the 8384 eligible 
motorists contacted, 85.4% provided a breath sample, 70.0%, an 
OF sample, and 39.1%, a blood sample. The regression analyses 
were conducted on 5912 participants with a breath test and an 
OF or blood test. Illegal drugs (COC, THC, street AM, and OPI) 
were investigated. 10.5% of  nondrinking drivers were using illegal 
drugs and 26% to 33% of  drivers with illegal blood alcohol con-
centration were using drugs [66]. 
Driving Impairment
There is a coincidence that OF analytes can indicate the state of  a 
subject if  presence of  drugs is detected, the impairment of  their 
driving ability and a better correlation between presence of  drugs 
in OF and impairment.
Some papers have reported data referent to driving, drug use and 
impairment. Driving behaviour and perceptions related to the fre-
quency of  driving under the influence of  THC and COC have 
been studied by means of  a questionnaire administered to peo-
ple in treatment for abuse of  COC or THC. The results indicate 
that COC and THC have different effects on driving and reduced 
driving ability was reported for COC as well as recklessness. The 
negative physical effects of  cannabis may reduce the likelihood of  
driving under the influence of  cannabis [67]. 
Regarding to THC and COC, the most representative drugs found 
in population in many countries, some considerations are derived 
referring to impairment in driving. A study dealing with marijuana 
and driving investigated the drugs and accident risk in fatally in-
jured drivers where THC was the most frequent detected (10%in 
this study). THC tended to show negative effect on relative risk 
when other drug groups showed an increase [68]. This phenom-
enon has also been seen elsewhere [69, 70]. The reason probably 
relates to the over compensation of  marijuana-using drivers on 
their driving skills, but risk analysis studies to investigate the con-
tribution of  drugs to accident causation are limited. Nevertheless 
recently various national surveys suggest that THC use is rising 
nationally. This present a problem for traffic security as research 
suggest that THC impairs driving ability. In California, cannabis 
involved driving has increased since 2007 [71]. 
A survey was performed and impairment observed. Urine, serum 
and in OF samples were collected and analyzed for THC, AM and 
its derivatives, OPI and COC. Police and medical officer observa-
tions of  impairment symptoms were rated and evaluated using a 
threshold value for the classification of  driving inability. Impair-
ment symptoms above threshold were observed (81.5%). Of  the 
cases with drugs detected in serum, 19.1% appeared not impaired 
which were the same with drug-positive OF. More persons with 
drug-positive urine samples appeared uninfluenced (32.7%). The 
data demonstrate that OF is superior to urine in correlating with 
serum analytical data and impairment symptoms of  drivers under 
the influence of  drugs of  abuse [72]. 
No impairment on basic driving skills are showed on drivers un-
der COC and AM although risk taking during driving is increased 
but few studies looked at the effects on driving of  illegal drugs 
and drugs users are not aware of  impairment in driving [59]. Our 
group has studied the concentration of  COC and its relationship 
with clinical symptoms in drivers suspected of  drug use. A total 
of  154 samples of  OF, which tested positive for COC in previous 
immunoassay screening, Cozart Drug Detector System, were con-
firmed using GC/MS method. In Catalonia, during 2007-2010, 
there were 1791 samples positive for COC among a total of  3468 
samples taken from drivers who tested positive for any drug of  
abuse. The evaluation of  clinical symptoms was through a ques-
tionnaire that was filled in by the police officers that collected the 
samples. The mean concentration of  cocaine was 4.11mg/l and 
median concentration was 0.38 mg/l (range 0.01-345.64 mg/l). 
Association between concentration and clinical impairment 
symptoms such as motor coordination, walking, speech, mood 
and state of  pupils were not significant [73]. 
However, detection of  drugs in OF is a sign of  recent drug use 
and impairment. New pharmacokinetic studies have been con-
ducted, optimal cut-offs have been proposed, and new studies 
have examined the correlation between impairment and OF drug 
concentrations.
Discussion
Data provided over DUID let know the magnitude of  the prob-
lem around the world. It has been estimated that the prevalence 
of  illicit drug use among the general driving population in Europe 
is in the range of  1-5 %. Studies are more frequent in Europe and 
United States than in other less developed countries. The preva-
lence of  the illegal drugs depends on the countries but in general 
THC and COC are the most prevalent drugs. In DUID context 
has been observed that majority of  incidence fell into the evening 
hours and early morning hours of  Saturday and Sunday.
Reported articles highlight the utility of  OF. The testing of  this 
matrix presents fewer ethical problems than blood or urine and 
that presence of  a drug correlate better with impairment than 
the presence of  drug metabolites in urine. Its utility to be used 
to detect drivers under the influence is undoubted. As it has been 
reviewed epidemiological research is often carried out on offend-
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ers and drivers involved in collisions.
During the last years, scientific and technological advances in OF 
collection, point-of-collection testing devices, and screening and 
confirmation methods were achieved. By optimizing the sampling 
and the analytical cut-offs, the potential of  OF as a confirmation 
matrix could be enhanced. In general it is considered that the de-
tection of  a psychoactive substance in OF taken at the roadside is 
highly predictive for the detection of  the corresponding drug or 
its metabolite in serum.
Nevertheless literature on proficiency testing to ensure reliability 
and comparability of  results is limited. Although OF testing is 
now commonplace in many monitoring programs, the greatest 
current limitation is the scarcity of  controlled drug administration 
studies available to guide interpretation [74]. For that reason is 
difficult to outline clear conclusions since other variables should 
be considered. The studies use different devices to collect and test 
the samples. The tests show different cut-offs, and different sensi-
bility, specificity accuracy and recovery are obtained. Regarding to 
analytical methods, confirmatory analysis also may differ among 
different laboratories; methods are developed for laboratories by 
LC/MS and GC/MS to determine several drugs and are validated 
according to their specifics conditions, so comparison may be 
done cautiously. Standardized protocols of  sample pretreatment 
are needed to link the detected concentrations to final conclu-
sions and development of  suitable proficiency testing schemes is 
required. Moreover, time of  last administration of  drugs, the dose 
and the route of  administration were unknown in many popula-
tions. At the same time search is needed on another variable, the 
detection time and half  life time of  elimination of  drugs in OF 
with different onsite analysis techniques and sampling. Additional 
research is needed to identify new biomarkers, determine drug 
detection windows, characterize OF adulteration techniques, and 
evaluate analyte's stability. Further more, interpretation of  screen-
ing of  the proofs done by trained personal is not guarantied most 
of  times and errors inter or intraobservators may be was not tak-
en in consideration. 
For that reason and despite the steady progress obtained along the 
time, some more work needs to be done, principally in the areas 
of  the sensitivity and the reliability of  on-site screening devices, 
particularly for cannabis, knowledge about passive contamina-
tion and more generalised proficiency testing. A broad scientific 
knowledge of  the many factors involved in determining test out-
come must be considered. More recent studies as the discovery of  
the presence of  THC-COOH, metabolite of  cannabis in OF, can 
contribute to solve the issue of  false-positive results caused by 
passive exposure to cannabis. Variables as oral contamination es-
pecially for orally consumed drugs must be considered to explain 
results like MDMA and THC use [75]. Another limitation is that 
due to large variation seen here, drug findings in OF should not 
be used to estimate the corresponding concentrations in whole 
blood (or vice versa).
However, it is important to stand out that the detection of  drugs 
in OF is a sign of  recent drug use and OF can be used for quali-
tative detection of  several drugs, in epidemiological prevalence 
studies. 
Related to legal aspects most countries have legislation that cov-
ers driving under the influence of  alcohol and/or drugs. Some 
countries have introduced zero-tolerance laws (per se laws), which 
prohibit the operation of  a motor vehicle while an illicit drug or 
its metabolite is present in the body, whether or not impairment 
is manifested but only in a few countries legislation  allows the 
use of  OF as a matrix for screening or confirmation. In the state 
of  Victoria, Australia, the use of  OF for evidentiary testing in the 
case of  THC and MA is allowed [76]. The first legal random drug 
testing program in OF since 2004 was organized  in that state 
[77]. Derived from ROSITA 2 Project other countries as Finland, 
Norway and Spain began to consider OF as a matrix to detect 
drugged drivers.
In Spain, in Catalonia region, police officers are carrying out pro-
grams to detect drugged drivers. More than 35000 proofs have 
been done and results let proofs going on, since OF is considered 
a proof  good enough to detect drugs consumption although no 
quantitative analysis is being carried out until now. Traffic Legisla-
tion fines drivers where qualitative presence of  drugs is detected 
and Spanish court yard and forensic settings are admitting the 
qualitative results of  these proofs.
Guidelines were proposed for workplace OF testing by SHAMSA 
and DRUID program, and standardization of  DRUID research. 
SHAMSA of  OF testing was delayed because questions about 
drug OF disposition were not yet resolved, and collection device 
performance and testing assays require improvement.
We have documented the many advances achieved in the use of  
OF as an alternative matrix that has an important role in DUID, 
treatment, workplace, and criminal justice programs According 
to these promising results police officers and judicial experts are 
keen to use OF for screening of  illegal drugs. Their ease of  use 
and diminished amount of  false positive results in comparison 
with urine screening will lead to more roadside tests and more 
appropriate juridical measures.
A September 2006 meeting of  international experts discussed the 
harmonization of  protocols for future research on drugged driv-
ing. The principal objective of  the meeting was to develop a con-
sensus report setting guidelines, standards, core data variables and 
other controls that would form the basis for future international 
research. A modified Delphi method was utilized to develop draft 
guidelines. The Guidelines Document was divided into three ma-
jor sections, each focusing upon different aspects of  drugged 
driving research. One of  them was roadside surveys, within the 
critical issue areas of  'behaviour', 'epidemiology' and 'toxicology' 
providing recommendations in these specific areas. These guide-
lines improve significantly the overall quality of  drugged driving 
research and facilitate future cross-study comparisons nationally 
and globally [78]. 
On the practical aspects of  implying a DUID legislation investi-
gation is specially focused on THC screening and quantification 
since cannabis is one of  the most prevalent illegal drugs [79].
In conclusion more publications focus on the usability of  OF for 
this purpose. Laboratory confirmation techniques, OF collection, 
choice of  cut-offs, stability and proficiency testing are important 
issues influencing interpretation of  results of  the presence of  il-
legal drugs in OF to detect subjects in DUID context.
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